Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Bicycle Therapeutics Plc ADR’s current trading price is -67.95% away from its 52-week high, while its distance from the 52-week low is 6.86%. The stock’s price range over this period has fluctuated between $8.60 and $28.67. The company, operating within the financial sector, had a trading volume of approximately 0.5 million for the day, which was noticeably higher than the average daily share volume of 0.32 million over the last 3 months.
Bicycle Therapeutics Plc ADR saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $28.67 on 10/16/24, while the lowest price for the same duration was marked at $8.60 on 03/26/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bicycle Therapeutics Plc ADR (BCYC) has experienced a quarterly decline of -36.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 634.66M and boasts a workforce of 305 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.11, with a change in price of -14.84. Similarly, Bicycle Therapeutics Plc ADR recorded 465,422 in trading volume during the last 100 days, posting a change of -61.76%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BCYC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
BCYC Stock Stochastic Average
Today, Bicycle Therapeutics Plc ADR’s raw stochastic average for the past 50 days stands at 8.81%, indicating a decline from the raw stochastic average of the last 20 days, which was 23.05%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 10.21% and 7.37% respectively.
BCYC Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -34.36%.However, over the last six months, we can see a stronger performance of -61.06%. Over the last 30 days, the price of BCYC has leaped by -18.82%. And in the last five days, it has fallen by -3.16%.
